Methicillin-resistant Staphylococcus aureus (MRSA) infections are an emerging problem in both children and adults throughout the United States. Skin and soft tissue infections are most common, however serious invasive disease can occur and may involve any anatomic site. The initial empiric therapy of suspected S. aureus infections will be influenced by the regional antimicrobial susceptibility patterns for the organism as well as the severity of the infection being treated. This article will review the epidemiology, clinical features, and treatment considerations for MRSA infections in children.